FDA Grants Regular Approval to Rucaparib for Metastatic Castration-Resistant Prostate Cancer By Ogkologos - January 29, 2026 300 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the TRITON3 study Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Belzutifan with Pembrolizumab for Adjuvant Treatment of Renal Cell Carcinoma How Decades of NCI Support Led to Groundbreaking Discoveries: The Story of Immune Checkpoint Inhibitors Adding Belzutifan to Pembrolizumab Prolongs DFS After Nephrectomy in Patients with ccRCC at Increased Risk for Recurrence MOST POPULAR Oxaliplatin-Based Adjuvant Chemotherapy Shows Good Tolerance and Similar Time To Recurrence... April 4, 2024 Using Aspirin to Prevent Breast Cancer Recurrence and Targeted Therapy for... February 14, 2022 Therapy Rottweiler, known as Dogtor Loki, Is Delivering ‘Hero Healing Kits’... April 16, 2020 Mom Warns Others After Little Girl’s Skin Blisters From ‘Margarita Burn’ July 31, 2019 Load more HOT NEWS Pembrolizumab Improves Survival in Advanced Triple-Negative Breast Cancer Longer Duration of Treatment with ICIs Associated with a Higher Rate... ¿Puede el uso de un microondas causar cáncer? New Areolar Incision Technique Leaves Almost No Scars for Breast Cancer...
